-
Molecular Oncology Long Weiwen/Liu Jian discovered ERK3 as an oncoprotein that promotes the development and progression of lung adenocarcinoma
Time of Update: 2021-11-13
On October 31, 2021, Wright State University's Long Weiwen research team and researcher Liu Jian from Zhejiang University Edinburgh University Joint College (ZJE) jointly published a titled "Conditional ERK3 overexpression cooperates with PTEN deletion to promotelung adenocarcinoma formation in mice" in Molecular Oncology.
-
The Narenmandula/Xu Zhihong team of Zhejiang University found that heat shock can specifically eliminate leukemia fusion oncoproteins
Time of Update: 2021-05-21
Since the 1970s, Chinese scientists Professor Zhang Tingdong, Academician Wang Zhenyi, Academician Chen Zhu, Academician Chen Saijuan and other research teams have pioneered the use of arsenic trioxide and all-trans retinoic acid to attack and degrade PML/RARα (P/R) fusion cancer protein for treatment APL has greatly improved the survival rate of patients, created a precedent for small-molecule drug targeted therapy, and established my country's international leading position in the field of APL therapy.
-
Science: discover the new role of space chromosome tissue of frequently mutated oncoprotein
Time of Update: 2019-05-29
May 29, 2019 / bioun / - a new study by Westad Institute reveals the function of protein arid1a, which is encoded by a gene that is one of the most common mutations in human cancer According to the st
-
Chinese scholars found Yap inhibitors of proto oncoprotein
Time of Update: 2014-02-25
Zhou Zhaocai, Zhang Leiyan and Ji Hongbin of Shanghai Institute of Biochemistry and cell research, Chinese Academy of Sciences and national protein science center, recently found an inhibitor of Yap,